Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells

被引:45
作者
Schmidt, K
Schrammel, A
Koesling, D
Mayer, B
机构
[1] Karl Franzens Univ Graz, Inst Pharmakol & Toxikol, A-8010 Graz, Austria
[2] Ruhr Univ Bochum, Inst Pharmakol & Toxikol, D-4630 Bochum, Germany
关键词
D O I
10.1124/mol.59.2.220
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
YC-1 is a direct activator of soluble guanylyl cyclase (sGC) and sensitizes the enzyme for activation by nitric oxide (NO) and CO. Because the potentiating effect of YC-1 on NO-induced cGMP formation in platelets and smooth muscle cells has been shown to be substantially higher than observed with the purified enzyme, the synergism between heme ligands and YC-1 is apparently more pronounced in intact cells than in cell-free systems. Here, we investigated the mechanisms underlying the synergistic activation of sGC by YC-1 and NO in endothelial cells. Stimulation of the cells with YC-1 enhanced cGMP accumulation up to similar to 100-fold. The maximal effect of YC-1 was more pronounced than that of the NO donor DEA/NO (similar to 20-fold increase in cGMP accumulation) and markedly diminished in the presence of L-N-G-nitroarginine, EGTA, or oxyhemoglobin. Because YC-1 did not activate endothelial NO synthase, the pronounced effect of YC-1 on cGMP accumulation was apparently caused by a synergistic activation of sGC by YC-1 and basal NO. The effect of YC-1 was further enhanced by addition of DEA/NO, resulting in a similar to 160-fold stimulation of cGMP accumulation. Thus, YC-1 increased the NO-induced accumulation of cGMP in intact cells by similar to8-fold. Addition of endothelial cell homogenate increased the stimulatory effect of YC-1 on NO-activated purified sGC from 1.2- to 3.7-fold. This effect was not observed with heat-denatured homogenates, suggesting that a heat-labile factor present in endothelial cells potentiates the effect of YC-1 on NO-activated sGC.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 25 条
[1]   Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line [J].
Becker, EM ;
Wunder, F ;
Kast, R ;
Robyr, C ;
Hoenicka, M ;
Gerzer, R ;
Schröder, H ;
Stasch, JP .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1999, 3 (01) :55-66
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Interaction of soluble guanylate cyclase with YC-1: Kinetic and resonance Raman studies [J].
Denninger, JW ;
Schelvis, JPM ;
Brandish, PE ;
Zhao, Y ;
Babcock, GT ;
Marletta, MA .
BIOCHEMISTRY, 2000, 39 (14) :4191-4198
[4]   Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme [J].
Friebe, A ;
Schultz, G ;
Koesling, D .
EMBO JOURNAL, 1996, 15 (24) :6863-6868
[5]   Mechanism of YC-1-induced activation of soluble guanylyl cyclase [J].
Friebe, A ;
Koesling, D .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :123-127
[6]  
Friedman JM, 1998, GENET MED, V1, P54
[7]   Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity [J].
Galle, J ;
Zabel, U ;
Hübner, U ;
Hatzelmann, A ;
Wagner, B ;
Wanner, C ;
Schmidt, HHHW .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (01) :195-203
[8]   NITRIC-OXIDE SIGNALING IN THE CENTRAL-NERVOUS-SYSTEM [J].
GARTHWAITE, J ;
BOULTON, CL .
ANNUAL REVIEW OF PHYSIOLOGY, 1995, 57 :683-706
[9]   NG-METHYL-L-ARGININE CAUSES ENDOTHELIUM-DEPENDENT CONTRACTION AND INHIBITION OF CYCLIC-GMP FORMATION IN ARTERY AND VEIN [J].
GOLD, ME ;
WOOD, KS ;
BYRNS, RE ;
FUKUTO, J ;
IGNARRO, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4430-4434
[10]   PURIFICATION OF SOLUBLE GUANYLYL CYCLASE FROM BOVINE LUNG BY A NEW IMMUNOAFFINITY CHROMATOGRAPHIC METHOD [J].
HUMBERT, P ;
NIROOMAND, F ;
FISCHER, G ;
MAYER, B ;
KOESLING, D ;
HINSCH, KD ;
GAUSEPOHL, H ;
FRANK, R ;
SCHULTZ, G ;
BOHME, E .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 190 (02) :273-278